148 related articles for article (PubMed ID: 35795090)
1. Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.
Liao LM; Gu ZB; Fang M; Yao GJ; Huang L
Int J Clin Exp Pathol; 2022; 15(6):241-246. PubMed ID: 35795090
[TBL] [Abstract][Full Text] [Related]
2. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
[TBL] [Abstract][Full Text] [Related]
4. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
[TBL] [Abstract][Full Text] [Related]
5. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
6. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
7. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
[TBL] [Abstract][Full Text] [Related]
9. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
[TBL] [Abstract][Full Text] [Related]
11. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.
Sakai M; Sohda M; Miyazaki T; Suzuki S; Sano A; Tanaka N; Inose T; Nakajima M; Kato H; Kuwano H
Anticancer Res; 2010 Mar; 30(3):851-6. PubMed ID: 20393006
[TBL] [Abstract][Full Text] [Related]
12. Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer.
Yu L; Wang G; Zhang Q; Gao L; Huang R; Chen Y; Tang Q; Liu J; Liu C; Wang H; Wang X
Oncol Lett; 2017 Mar; 13(3):1194-1200. PubMed ID: 28454233
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
[TBL] [Abstract][Full Text] [Related]
14. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
15. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
Front Genet; 2020; 11():593273. PubMed ID: 33193737
[TBL] [Abstract][Full Text] [Related]
16. Enhanced karyopherin-α2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms.
Kubo N; Araki K; Altan B; Hoshino K; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kato T; Hirai K; Yokobori T; Saito F; Suzuki H; Kuwano H; Shirabe K
Pancreatology; 2017; 17(4):611-616. PubMed ID: 28476582
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
[TBL] [Abstract][Full Text] [Related]
18. KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
Huang L; Zhou Y; Cao XP; Lin JX; Zhang L; Huang ST; Zheng M
Tumour Biol; 2017 Jun; 39(6):1010428317706289. PubMed ID: 28651492
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
Li C; Ji L; Ding ZY; Zhang QD; Huang GR
Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
[TBL] [Abstract][Full Text] [Related]
20. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
